Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-023733
Filing Date
2023-05-10
Accepted
2023-05-09 18:42:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20008400x6_defa14a.htm DEFA14A 81382
  Complete submission text file 0001140361-23-023733.txt   82685
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-11460 | Film No.: 23903755
SIC: 2834 Pharmaceutical Preparations